Cargando…

Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype Antigen

The attenuated live M. bovis Bacille-Calmette-Guérin (BCG) is still the sole vaccine used against tuberculosis, but confers only variable efficacy against adult pulmonary tuberculosis (TB). Though no clear explanation for this limited efficacy has been given, different hypotheses have been advanced,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruffaerts, Nicolas, Romano, Marta, Denis, Olivier, Jurion, Fabienne, Huygen, Kris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494193/ https://www.ncbi.nlm.nih.gov/pubmed/26344474 http://dx.doi.org/10.3390/vaccines2010181

Ejemplares similares

Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen
por: Bruffaerts, Nicolas, et al.
Publicado: (2015)

Analysis of the Vaccine Potential of Plasmid DNA Encoding Nine Mycolactone Polyketide Synthase Domains in Mycobacterium ulcerans Infected Mice
por: Roupie, Virginie, et al.
Publicado: (2014)

M.tuberculosis Mutants Lacking Oxygenated Mycolates Show Increased Immunogenicity and Protective Efficacy as Compared to M. bovis BCG Vaccine in an Experimental Mouse Model
por: Hedhli, Dorsaf, et al.
Publicado: (2013)

Mucosal and Systemic Immune Responses to Mycobacterium tuberculosis Antigen 85A following Its Co-Delivery with CpG, MPLA or LTB to the Lungs in Mice
por: Todoroff, Julie, et al.
Publicado: (2013)

In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination
por: Coppola, Mariateresa, et al.
Publicado: (2021)

Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis
por: Festjens, Nele, et al.
Publicado: (2011)

The Immunodominant T-Cell Epitopes of the Mycolyl-Transferases of the Antigen 85 Complex of M. tuberculosis
por: Huygen, Kris
Publicado: (2014)

Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle
por: Dean, Gillian S., et al.
Publicado: (2015)

Field evaluation of the efficacy of Mycobacterium bovis BCG vaccine against tuberculosis in goats
por: Vidal, Enric, et al.
Publicado: (2017)

Vaccination-related Mycobacterium bovis BCG Infection
por: Liberek, Anna, et al.
Publicado: (2006)

Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
por: Dellagostin, Odir Antônio, et al.
Publicado: (2022)

Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis
por: Tirado, Yanely, et al.
Publicado: (2015)

Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep
por: Balseiro, Ana, et al.
Publicado: (2017)

Antitumor Activity of Synthetic Oligonucleotides with Sequences from cDNA Encoding Proteins of Mycobacterium bovis BCG
por: Kataoka, Tetsuro, et al.
Publicado: (1992)

Complete Genome Sequence of Mycobacterium bovis BCG SL222 Sofia, the First WHO Reference Reagent for the M. bovis BCG Vaccine of the Russian BCG-I Substrain
por: Panaiotov, Stefan, et al.
Publicado: (2021)

Recombinant AhpC antigen from Mycobacterium bovis boosts BCG-primed immunity in mice
por: DÜZENLİ, Özgün Fırat, et al.
Publicado: (2021)

Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur
por: Berrêdo-Pinho, Marcia, et al.
Publicado: (2011)

Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant
por: Keller, Peter M, et al.
Publicado: (2008)

Immunogenicity and cross-reactivity against Mycobacterium tuberculosis of proteoliposomes derived from Mycobacterium bovis BCG
por: Reyes, Fátima, et al.
Publicado: (2013)

Biochemical characterization of the maltokinase from Mycobacterium bovis BCG
por: Mendes, Vítor, et al.
Publicado: (2010)

Mycobacterium bovis BCG–Associated Osteomyelitis/Osteitis, Taiwan
por: Chiu, Nan-Chang, et al.
Publicado: (2015)

Optimisation of Mycobacterium bovis BCG Fermentation and Storage Survival
por: Pascoe, Jordan, et al.
Publicado: (2020)

Formulation of a mmaA4 Gene Deletion Mutant of Mycobacterium bovis BCG in Cationic Liposomes Significantly Enhances Protection against Tuberculosis
por: Derrick, Steven C., et al.
Publicado: (2012)

Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route
por: Xu, Zhengzhong, et al.
Publicado: (2023)

Multiple small RNAs identified in Mycobacterium bovis BCG are also expressed in Mycobacterium tuberculosis and Mycobacterium smegmatis
por: DiChiara, Jeanne M., et al.
Publicado: (2010)

The Effect of Oral Vaccination with Mycobacterium bovis BCG on the Development of Tuberculosis in Captive European Badgers (Meles meles)
por: Chambers, Mark A., et al.
Publicado: (2017)

Complement Dependent and Independent Interaction Between Bovine Conglutinin and Mycobacterium bovis BCG: Implications in Bovine Tuberculosis
por: Mehmood, Arshad, et al.
Publicado: (2019)

Whole-Genome Sequence of Mycobacterium bovis BCG-1 (Russia)
por: Ludannyy, R., et al.
Publicado: (2015)

Mycobacteria Bovis osteomyelitis following intravesical BCG for bladder cancer
por: Seegobin, Karan, et al.
Publicado: (2017)

Phosphate starvation enhances phagocytosis of Mycobacterium bovis/BCG by macrophages
por: Espinosa-Cueto, Patricia, et al.
Publicado: (2020)

BCG vaccine: Disseminated Mycobacterium bovis infection: case report
Publicado: (2021)

Mycobacterium bovis BCG Surface Antigens Expressed under the Granuloma-Like Conditions as Potential Inducers of the Protective Immunity
por: Chen, Yingyu, et al.
Publicado: (2019)

Selective delipidation of Mycobacterium bovis BCG enables direct pulmonary vaccination and enhances protection against Mycobacterium tuberculosis
por: Moliva, Juan I., et al.
Publicado: (2019)

Artificially induced MAIT cells inhibit M. bovis BCG but not M. tuberculosis during in vivo pulmonary infection
por: Yu, Huifeng, et al.
Publicado: (2020)

Hyperglycaemia is inversely correlated with live M. bovis BCG‐specific CD4(+) T cell responses in Tanzanian adults with latent or active tuberculosis
por: Boillat‐Blanco, Noémie, et al.
Publicado: (2018)

Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses
por: Back, Yong Woo, et al.
Publicado: (2019)

Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c
por: Gunasena, Manuja, et al.
Publicado: (2022)

Glutamate Dehydrogenase Is Required by Mycobacterium bovis BCG for Resistance to Cellular Stress
por: Gallant, James L., et al.
Publicado: (2016)

Identification of four novel DC-SIGN ligands on Mycobacterium bovis BCG
por: Carroll, Maria V., et al.
Publicado: (2010)

Complete Genome Sequence of Mycobacterium bovis Strain BCG-1 (Russia)
por: Sotnikova, Evgeniya A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4t6ejmnjs5mjkc65052fpdemmb